跳转至内容
Merck
CN
  • Development of 3-iodophenylisothiocyanate for radioiodination of monoclonal antibodies.

Development of 3-iodophenylisothiocyanate for radioiodination of monoclonal antibodies.

International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes (1992-11-01)
S Ram, D J Buchsbaum
摘要

A new radioiodination reagent, 3-iodophenylisothiocyanate (3-IPI) has been developed for coupling to monoclonal antibodies. The starting material, 3-tri-n-butylstannylphenylisothiocyanate was prepared via a reaction of hexabutylditin with 3-bromoaniline, followed by treatment with thiophosgene with an overall yield of 72%. The radioiodination of this tin precursor with Na[125I]I/iodogen in chloroform gave 3-[125I]IPI in 23-55% radiochemical yield and 81-99.6% radiochemical purity. Purification of the impure product by high pressure liquid chromatography increased the radiochemical purity of the product up to 99%. These results suggest that 3-IPI may be a useful ligand for radioiodination and coupling to a variety of monoclonal antibodies.